Department of Health and Human Services (HHS) announced on June 23 that the department has signed a new $35 million contract with Protein Sciences Corporation, Inc. for new way to make influenza vaccine.  The contract could be extended up to five years at a total cost of approximately $147 million.  HHS says that the Baculovirus Expression Vector System (BEVS) technology could help the nation respond to emerging infectious diseases such as seasonal and pandemic flu.→HHS news release